X0609 4/A 2026-06-12 2026-06-16 0001611115 Omada Health, Inc. OMDA 0002021724 Gracey Craig false C/O OMADA HEALTH, INC. 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 false true false false Chief Accounting Officer true Common Stock 2026-06-12 4 M false 6250 6.57 A 22335 D Common Stock 2026-06-12 4 S false 6894 17.4243 D 15441 D Stock Option (Right to Buy) 6.57 2026-06-12 4 M false 6250 0 D 2034-10-23 Common Stock 6250 43750 D This Form 4/A restates in its entirety the original Form 4 filed on 6/16/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. This transaction was executed in multiple trades at prices ranging from $17.04 to $17.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. /s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey 2026-07-08